Scarica l'app Stockscreener
1.94
4.28%
0.07
Precedente Chiudi:
$1.87
Aprire:
$1.86
Volume 24 ore:
199.12K
Relative Volume:
0.77
Capitalizzazione di mercato:
$105.01M
Reddito:
-
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-2.3095
EPS:
-0.84
Flusso di cassa netto:
$-18.45M
1 W Prestazione:
+0.00%
1M Prestazione:
+21.87%
6M Prestazione:
+95.00%
1 anno Prestazione:
+180.98%
Intervallo 1D:
$1.8134
$1.97
Intervallo di 1 settimana:
$1.62
$2.16
Portata 52W:
$0.713
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Nome
Quince Therapeutics Inc
Settore
Industria
Telefono
415-910-5717
Indirizzo
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Confronta QNCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.955 | 100.44M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.02 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.17 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.91 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.23 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Iniziato | Oppenheimer | Outperform |
Quince Therapeutics Inc Borsa (QNCX) Ultime notizie
How to forecast Quince Therapeutics Inc. trends using time seriesJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
Will Quince Therapeutics Inc. stock deliver shareholder value2025 Volatility Report & Weekly Hot Stock Watchlists - newser.com
Is Quince Therapeutics Inc. stock a good choice for value investors2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
Is Quince Therapeutics Inc. trending in predictive chart models2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com
Quince Therapeutics Inc. stock daily chart insightsMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Quince Therapeutics' (QNCX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Tel - PharmiWeb.com
Quince Therapeutics presents A-T walking capacity data at neurology meeting By Investing.com - Investing.com Canada
Quince Therapeutics (QNCX) Highlights Walking Study at Neurology Meeting - GuruFocus
Quince Therapeutics presents A-T walking capacity data at neurology meeting - Investing.com
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting - Business Wire
Quince Therapeutics Inc. stock outlook for YEAREarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Visual trend scoring systems applied to Quince Therapeutics Inc.Risk Management & Real-Time Volume Analysis Alerts - newser.com
Has Quince Therapeutics Inc. formed a bullish divergenceEarnings Overview Report & High Return Stock Watch Alerts - newser.com
Can Quince Therapeutics Inc. stock hit analyst price targetsJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) PT at $8.14 - Defense World
Is Quince Therapeutics (NASDAQ:QNCX) Using Too Much Debt? - simplywall.st
What drives Quince Therapeutics Inc stock priceFinancial Sector Performance & Minimal Investment Capital - earlytimes.in
Will Quince Therapeutics Inc. bounce back from current supportWatch List & Reliable Price Breakout Alerts - newser.com
Applying Wyckoff theory to Quince Therapeutics Inc. stock2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Applying Elliott Wave Theory to Quince Therapeutics Inc.Recession Risk & Verified Momentum Watchlists - newser.com
Oppenheimer Sticks to Their Buy Rating for Quince Therapeutics (QNCX) - The Globe and Mail
Oppenheimer Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Chart based analysis of Quince Therapeutics Inc. trendsJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Quince Therapeutics stock maintains Market Outperform rating at Citizens - Investing.com
Aqua Metals files to sell 1M shares of common stock for holders - MSN
Transcript : Quince Therapeutics, Inc.Analyst/Investor Day - MarketScreener
Quince Therapeutics (NASDAQ:QNCX) Stock Price Up 1.2% – Time to Buy? - Defense World
Quince Therapeutics Inc Azioni (QNCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):